At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme ’s Lemtrada in Pivotal Studies
FDA Approves Genzyme ’s Cerdelga™ (eliglustat) Capsules
Sanofi: Study Shows Positive Results from Lemtrada Tests
FDA Approves Use of Menactra® Vaccine for Booster Immunization Against Potentially Deadly Disease
Regeneron and Sanofi Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014
Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014
Sanofi Gets U.S. FDA Approval for Gaucher Disease Treatment
A roundup of investment news.
Focusing on stocks with the most visible cash flows has been a winning strategy, and this screen can find them.